Uzbekistan Digital Health Platform - Integrations
0.1.0 - ci-build
Uzbekistan Digital Health Platform - Integrations
0.1.0 - ci-build
Uzbekistan Digital Health Platform - Integrations - Local Development build (v0.1.0) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions
| Rasmiy URL: https://terminology.dhp.uz/fhir/integrations/CodeSystem/dhis-observation-component-code-cs | Versiya: 0.1.0 | ||||
| Draft 2026-07-13 holatiga ko‘ra | Kompyuterda qayta ishlanadigan nom: DHISObservationComponentCodeCS | ||||
Local code system of tuberculosis observation component codes, including drug-susceptibility-test agents, used by the DHIS information system with Russian and English designations. The DHIS Observation Component Code to LOINC ConceptMap records the LOINC [Susceptibility] concept for the drug agents; in resources use the LOINC code directly wherever an exact match exists (see the DHIS Observation Component Code ValueSet), keeping a local code only where no exact LOINC match exists.
Ushbu kod tizimi quyidagi qiymatlar to‘plamida ishlatilgan:
Language: uz
This case-sensitive code system https://terminology.dhp.uz/fhir/integrations/CodeSystem/dhis-observation-component-code-cs defines the following codes in a Is-A hierarchy:
Additional Language Displays
| Code | English (English, en) | Русский (Russian, ru) |
| tub004-0001 | INH high MIC result | Результат INH ↑МИК |
| tub004-0002 | INH low MIC / ETH result | Результат INH ↓МИК / ETH |
| tub004-0003 | FQL high MIC result | Результат FQL ↑МИК |
| tub004-0004 | FQL low MIC result | Результат FQL ↓МИК |
| tub004-0005 | AMK/KAN/CAP result | Результат AMK/KAN/CAP |
| tub004-0006 | AMK/KAN result | Результат AMK/KAN |
| tub004-0007 | Rifampicin (1.0 mg/mL) | Рифампицин (1,0 мг/мл) |
| tub004-0008 | Isoniazid (0.1 mg/mL) | Изониазид (0,1 мг/мл) |
| tub004-0009 | Ethambutol (5.0 mg/mL) | Этамбутол (5,0 мг/мл) |
| tub004-0010 | Pyrazinamide (100 mg/mL) | Пиразинамид (100 мг/мл) |
| tub004-0011 | Levofloxacin (2.0 mg/mL) | Левофлоксацин (2,0 мг/мл) |
| tub004-0012 | Moxifloxacin (1.0 mg/mL) | Моксифлоксацин (1,0 мг/мл) |
| tub004-0013 | Moxifloxacin (0.25 mg/mL) | Моксифлоксацин (0,25 мг/мл) |
| tub004-0014 | Gatifloxacin (0.25 mg/mL) | Гатифлоксацин (0,25 мг/мл) |
| tub004-0015 | Amikacin (1.0 mg/mL) | Амикацин (1,0 мг/мл) |
| tub004-0016 | Prothionamide (2.5 mg/mL) | Протионамид (2,5 мг/мл) |
| tub004-0017 | Linezolid (1.0 mg/mL) | Линезолид (1,0 мг/мл) |
| tub004-0018 | Clofazimine (1.0 mg/mL) | Клофазимин (1,0 мг/мл) |
| tub004-0019 | Bedaquiline (1.0 mg/mL) | Бедаквилин (1,0 мг/мл) |
| tub004-0020 | Delamanid (0.06 mg/mL) | Деламанид (0,06 мг/мл) |
| tub004-0021 | Pretomanid (1.0 mg/mL) | Претоманид (1,0 мг/мл) |
| tub004-0022 | Rifampcin | Рифампциин |
| tub004-0023 | Isoniazid ↑MIC | Изониazid ↑МИK |
| tub004-0024 | Isoniazid ↓MIC | Изониazid ↓МИK |
| tub004-0025 | Ethionamide-Prothionamide | Этионамид-Протионамид |
| tub004-0026 | Moxifloxacin ↑MIC | Моксифлоксацин ↑МИК |
| tub004-0027 | Moxifloxacin ↓MIC | Моксифлоксацин ↓МИК |
| tub004-0028 | Levofloxacin | Левофлоксацин |
| tub004-0029 | Amikacin | Амикацин |
| tub004-0030 | Kanamycin | Канамицин |
| tub004-0031 | CM/AS isolate identification | Идентификация изолята CM/AS |
| tub004-0032 | Grading | Градация |
| tub004-0033 | Culture identification | Идентификация культуры |
| tub004-0034 | Result of M. tuberculosis complex detection | Результат определения M. tuberculosis complex |
| tub004-0035 | CM/AS isolate identification | Идентификация изолята CM/AS |
| tub004-0036 | ART (Antiretroviral Therapy) | АРВТ (антиретровирусная терапия) |
| tub004-0037 | KTR begin | КТР начато |